Resource Investing Sprott Inc. Announces 33% Dividend Increase and Declares Third Quarter 2025 Dividend
Cardiol Therapeutics' Phase II ARCHER Trial Results to be Presented at the European Society of Cardiology Scientific Meeting on Myocardial & Pericardial Diseases